Latest News - Glaucoma

Monday, February 27, 2017 | Glaucoma, Bausch+Lomb, Nicox

Bausch + Lomb And Nicox Resubmit FDA New Drug Application For Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb and Nicox announced the resubmission of a new drug application (NDA) to the FDA seeking approval for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene bunod is an IOP-lowe…

Read the full story

Friday, February 24, 2017 | Conferences, Glaucoma, Inotek Pharmaceuticals

Inotek Pharmaceuticals Announces Poster Presentations on Trabodenoson at the American Glaucoma Society 2017 Annual Meeting

Inotek Pharmaceuticals announced three poster presentations at the American Glaucoma Society 2017 Annual Meeting to be held March 2-5 in Coronado, California. The presentation details are as follows: …

Read the full story

Friday, February 24, 2017 | Glaucoma, Medical Studies

Surgical Techniques Showcased at Glaucoma Meeting

A new analysis of 5-year pooled data from two studies, along with highly anticipated reports on new surgical techniques, will be in the spotlight at the upcoming American Glaucoma Society (AGS) 2017 A…

Read the full story

Thursday, February 23, 2017 | Glaucoma, Partnerships, Santen

Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

Santen and twoXAR, an artificial intelligence-driven biopharmaceutical company, announced that the two companies have entered into a strategic research collaboration focused on the identification of n…

Read the full story

Tuesday, February 14, 2017 | Glaucoma, Allergan, MIGS

Allergan Announces First Commercial Use of XEN Glaucoma Treatment System in the US

Allergan announced that its XEN Glaucoma Treatment System is now being used by US surgeons to treat refractory glaucoma. The XEN Glaucoma Treatment System, consisting of the XEN45 Gel Stent and the XE…

Read the full story

Monday, January 09, 2017 | Glaucoma, Aerie Pharmaceuticals

Aerie Pharmaceuticals Enters into Lease Agreement for New Manufacturing Plant in Ireland

Aerie Pharmaceuticals announced that it has entered into a lease agreement with the Industrial Development Agency (IDA) of Ireland for a new manufacturing plant in Athlone, Ireland. This will be Aerie…

Read the full story

Monday, December 12, 2016 | Glaucoma, Medical Studies

Three-year Study Shows Significant Advantages of CLASS (CO2 Laser Assisted Sclerectomy Surgery) for Patients with Glaucoma

IOPtima announced the publication of 3-year follow up data from a multicenter study of patients undergoing CLASS (CO2 Laser Assisted Sclerectomy Surgery) with IOPtima’s IOPtiMate CO2 laser syste…

Read the full story

Monday, December 12, 2016 | Glaucoma, Medical Studies, Glaukos Corporation

Study Published in Journal of Glaucoma Evaluates a Single Glaukos iStent Trabecular Micro-Bypass Stent as a Standalone Procedure

Glaukos Corporation announced that a study published recently in the Journal of Glaucoma showed that a single iStent Trabecular Micro-Bypass Stent significantly reduced IOP when implanted as a standal…

Read the full story

Monday, December 12, 2016 | Glaucoma, Medical Studies

Antihypertensive Medications May Have Protective Effect Against Developing Glaucoma

Antihypertensive medications may have a preventive effect on developing glaucoma in people 40 years old or older, according to results of a study of the Danish population[1]. "Cardiologists shoul…

Read the full story

Thursday, December 01, 2016 | Glaucoma

Zika and Glaucoma Linked for First Time in New Study

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus dur…

Read the full story

Wednesday, November 23, 2016 | Glaucoma

Virtual Glaucoma Clinics Appear Safe, Study Finds

Remote assessment of glaucoma patients appears to be a safe and practical means of monitoring this chronic disease, according to U.K. researchers. "Although meeting our patients face to face has …

Read the full story

Tuesday, November 08, 2016 | Clinical Trials, Glaucoma, Medical Studies, Glaukos Corporation, MIGS

New International Study Highlights IOP-Lowering Performance of Glaukos iStent inject Trabecular Micro-Bypass in Standalone Procedure

Glaukos announced that in a study published in Advances in Therapy, 100% of 57 phakic eyes with open angle glaucoma achieved a ≥ 20% reduction in unmedicated IOP 1 year after implantation of the iS…

Read the full story

Monday, October 31, 2016 | Clinical Trials, Glaucoma, Glaukos Corporation, MIGS

Report: iStent Trabecular Micro-Bypass Stent Reduced IOP and Medication Use in Predominately Hispanic Glaucoma Patient Population

Glaukos Corporation announced that a study of 134 predominantly Hispanic eyes with open-angle glaucoma (OAG), published in Clinical Ophthalmology, showed mean IOP of 12.9 mm Hg and a 61% decrease in m…

Read the full story

Thursday, October 27, 2016 | Clinical Trials, Glaucoma, Aerie Pharmaceuticals

Aerie Pharmaceuticals Reports Positive Topline Efficacy Results of Rocket 4 Phase 3 Trial of Rhopressa

Aerie Pharmaceuticals reported the successful 90-day topline efficacy results of its Rocket 4 phase 3 clinical trial of product candidate Rhopressa, a novel once-daily eye drop being tested for its ab…

Read the full story

Tuesday, October 18, 2016 | Glaucoma, Medical Studies

Promise of Gene Therapy for Glaucoma Shines Bright in Award-Winning Image

Whether you see the gossamer wings of a butterfly or the delicate opened petals of a flower, there is beauty in the eye of the beholder - a mouse retina described and visually captured by scientists a…

Read the full story
Load More